VIICTR
Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Cabozantinib versus Everolimus in Advanced Renal-Cell Carcinoma.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Cabozantinib versus Everolimus in Advanced Renal-Cell Carcinoma.
Cabozantinib versus Everolimus in Advanced Renal-Cell Carcinoma. N Engl J Med. 2015 Nov 05; 373(19):1814-23.
View in:
PubMed
subject areas
Adult
Aged
Aged, 80 and over
Anilides
Antineoplastic Agents
Carcinoma, Renal Cell
Disease-Free Survival
Everolimus
Female
Humans
Kidney Neoplasms
Male
Middle Aged
Pyridines
Quality of Life
Sirolimus
Survival Analysis
authors with profiles
NIZAR M TANNIR